William Blair & Company’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$385K Sell
18,722
-1,277
-6% -$28.8K ﹤0.01% 1240
2025
Q4
$474K Buy
19,999
+400
+2% +$9.74K ﹤0.01% 1163
2025
Q3
$488K Sell
19,599
-40
-0.2% -$861 ﹤0.01% 1125
2025
Q2
$452K Hold
19,639
﹤0.01% 1117
2025
Q1
$441K Hold
19,639
﹤0.01% 1120
2024
Q4
$384K Buy
19,639
+25
+0.1% +$495 ﹤0.01% 1184
2024
Q3
$357K Sell
19,614
-29,100
-60% -$555K ﹤0.01% 1228
2024
Q2
$847K Sell
48,714
-2,850
-6% -$50.5K ﹤0.01% 934
2024
Q1
$1.01M Buy
51,564
+28,689
+125% +$606K ﹤0.01% 862
2023
Q4
$527K Sell
22,875
-723,320
-97% -$16.2M ﹤0.01% 1057
2023
Q3
$17.2M Buy
746,195
+57,881
+8% +$1.47M 0.07% 217
2023
Q2
$18M Sell
688,314
-107,006
-13% -$2.83M 0.07% 217
2023
Q1
$22M Buy
795,320
+83,029
+12% +$2.19M 0.09% 192
2022
Q4
$16.2M Buy
712,291
+40,325
+6% +$1.12M 0.07% 220
2022
Q3
$22.9M Buy
671,966
+56,824
+9% +$2.1M 0.11% 173
2022
Q2
$17.9M Buy
615,142
+597,730
+3,433% +$15.2M 0.08% 207
2022
Q1
$465K Buy
17,412
+1,463
+9% +$34.5K ﹤0.01% 1181
2021
Q4
$413K Buy
+15,949
New +$398K ﹤0.01% 1292

Other funds holding PRVA

William Blair & Company's PRVA Position: Q1 2026 in Review

William Blair & Company reduced its Privia Health (PRVA) stake by 6.4% in Q1 2026, selling an estimated $28.8K and leaving 18,722 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

William Blair & Company first reported a position in PRVA in Q4 2021 and has held it in 18 quarters since. The position peaked at $22.9M in Q3 2022. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • William Blair & Company held 18,722 shares of Privia Health worth $385K as of Q1 2026.
  • William Blair & Company sold 1,277 Privia Health shares in Q1 2026, an estimated $28.8K.
  • Privia Health made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1240 holding.
  • William Blair & Company first reported a position in Privia Health in Q4 2021 and has held it in 18 quarters since.
  • William Blair & Company's Privia Health position peaked at $22.9M in Q3 2022.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.